This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.15% per year. These returns cover a period from January 1, 1988 through June 3, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Conglomerate 3M’s focus on business transformation — with moves like the localization of decision making and integration of supply chains — enhances its competitive advantage. Also, its recognized product brands and investments in innovation are compelling. Inorganic actions (buyouts and divestments) are added advantages. Acelity, bought in October 2019, is predicted to aid 3M’s medical solutions business. Being one of the largest manufacturers of respiratory masks, the coronavirus outbreak has added to the company’s growth potential.
3M (MMM) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
3M (MMM) closed the most recent trading day at $128.37, moving -1.41% from the previous trading session.
The Zacks Analyst Blog Highlights NVIDIA, HSBC Holdings, 3M, BP, and PNC Financial Services
by Zacks Equity Research
NVIDIA, HSBC Holdings, 3M, BP, and PNC Financial Services are part of Zacks top Analyst Blog.
3M (MMM) Gains But Lags Market: What You Should Know
by Zacks Equity Research
3M (MMM) closed at $130.05 in the latest trading session, marking a +0.16% move from the prior day.
Top Stock Reports for NVIDIA, HSBC & 3M Company
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including NVIDIA Corporation (NVDA), HSBC Holdings plc (HSBC) and 3M Company (MMM).
3M (MMM) to Divest Neoplast & Neobun Brands to Selic Corp
by Zacks Equity Research
3M's (MMM) portfolio restructuring actions are expected to help the company focus on its core business areas and drive growth.
3M (MMM) Stock Moves -1.86%: What You Should Know
by Zacks Equity Research
3M (MMM) closed the most recent trading day at $130.33, moving -1.86% from the previous trading session.
Here's Why You Can Consider Investing in 3M (MMM) Stock Now
by Zacks Equity Research
3M (MMM) stands to benefit from strength across its businesses, acquired asset and shareholder-friendly policies.
General Electric (GE) Unit, Climavision Forge a Relationship
by Zacks Equity Research
General Electric (GE) and Climavision's partnership will enable the electric utility clients to predict adverse weather conditions and protect grids against natural calamities.
Are You Looking for a High-Growth Dividend Stock?
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does 3M (MMM) have what it takes? Let's find out.
Danaher (DHR) Exhibits Bright Prospects, Headwinds Persist
by Zacks Equity Research
Danaher (DHR) gains from solid demand for its products, acquired assets and shareholder-friendly policies. However, escalating costs and high debt levels remain concerns.
General Electric (GE) Arm Wins Steam Turbine Deal From BHEL
by Zacks Equity Research
General Electric's (GE) business unit GE Steam Power clinches a deal from BHEL to offer three nuclear steam turbines for NPCIL's domestic nuclear project in India.
Honeywell (HON) Unveils Carbon & Energy Management Solution
by Zacks Equity Research
Honeywell's (HON) Carbon and Energy Management solution helps making buildings sustainable and energy-efficient by continuously monitoring the energy consumption and carbon-emission levels.
ITT Invests in CRP, Boosts Foothold in Material Science
by Zacks Equity Research
ITT's investment in CRP will allow it to acquire additive manufacturing technology capabilities and strengthen its position in the material science space.
MMM vs. HON: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
MMM vs. HON: Which Stock Is the Better Value Option?
Honeywell (HON) Exhibits Strong Prospects, Endures Risks
by Zacks Equity Research
Honeywell (HON) is poised to benefit from its exposure in the diverse end markets, acquired assets and shareholder-friendly policies. However, cost woes and supply-chain bottlenecks remain a concern.
Carlisle (CSL) Appears to be a Solid Bet, Up 30.2% in a Year
by Zacks Equity Research
Carlisle (CSL) stands to benefit from its strength across its end markets, robust backlog level, acquired assets and shareholder-friendly policies.
Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
3M (MMM) Stock Moves -0.99%: What You Should Know
by Zacks Equity Research
3M (MMM) closed at $145.42 in the latest trading session, marking a -0.99% move from the prior day.
Why 3M (MMM) is a Great Dividend Stock Right Now
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does 3M (MMM) have what it takes? Let's find out.
The Zacks Analyst Blog Highlights 3M, Cigna, UnitedHealth Group, Exxon Mobil, and ConocoPhillips
by Zacks Equity Research
3M, Cigna, UnitedHealth Group, Exxon Mobil, and ConocoPhillips are part of Zacks top Analyst Blog
3M (MMM) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
3M (MMM) closed at $146.37 in the latest trading session, marking a -1.96% move from the prior day.
Volatility Reigns Supreme on Wall Street: Top 5 Picks for June
by Nalak Das
We have narrowed our search to five U.S. corporate behemoths (market capital > $50 billion). These are: MMM, CI, UNH, XOM and COP.
MMM vs. HON: Which Stock Is the Better Value Option?
by Zacks Equity Research
MMM vs. HON: Which Stock Is the Better Value Option?
Why Is 3M (MMM) Up 1.1% Since Last Earnings Report?
by Zacks Equity Research
3M (MMM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
ITT Gains From Solid End Markets & Habonim Buyout Amid Risks
by Zacks Equity Research
ITT stands to gain from solid momentum across its end markets, acquisition and growth investments. Rising costs and expenses and high capital expenditures might affect its performance.